The Blidepsina, An antididummer drug used for many years Antochemistry field, It has the power to treat different viruses like this SARS-COV-2, Mers, Zika, sympathetic respiratory virus (VRS, bronchitis), hepatitis C and herpes, Interior Alia. It has been proven by A The study of IrsicaIixa, Center promoted by La Kaisa and the recently published Catalonia Ministry of Health ‘Nature Communication’. This drug is effective against continuous kovit.
“This is a very important invention because we have to think that There will be new infections in the future. We need antivirus with the ability to cope with Different families virus “, Irisikicksa’s Chief Intelligent confirms Catalonia’s newspaper, Noori Iskuvirdo-Aszos. “A strategy of Blidite is that it allows to fight viruses in the future now in the future We don’t know ”, Duck.
At present, doctors They have no useful treatments For many viruses and, on many occasions, the only way to thank one’s own The immune system. However, diminishing the polygnee Counter -cellular functions Beyond its main action point. When you stop you The treatment goal is, This drug stimulates changes in other molecular processes that are obviously disconnected, which creates a unique form, which defines the research group COMOr “molecular track”.
As a left account, it was known that this treatment was from the beginning of the infection “Virus prevention effect” against Gov -19. Researchers have been reading this for many years, thanks to them “Treat Diana”. “We have seen that it allows us to predict its virus prevention against this and other viruses,” he says. The first studies in laboratory show “medical performance” in other viruses against herpes, Zika, HRS or hepatitis C. But You have to do more clinical trials, This researcher needs.
Came into effect against Govid -19
Studies made with this drug at the beginning of the infection showed them Advantage COVID-19. “However, when a study was carried out about its performance, we found a limit: (this study) was carried out in A The moment that many have already been vaccinated, It is difficult to have a large number of patients, ”the left says “Reduced the number of days” Infected with SARS-COV-2 They depend on oxygen to breathe. “We found a course that reflects the treatment of people with this drug Two days less oxygen than others ”, forSegura.
La plytidipsina Prevent an essential process of survival of cells and viruses: Protein package. The study reveals that cells will compensate for this block by activation Alternative ways of the protein set, This allows them to survive. However, many viruses cannot take advantage of these alternatives, therefore, their replica will stop.
In the laboratory, prevents Blideepsin Replica of SARS-COV-2, MRS, Hepatitis C virus, Zika, simple herpes and respiratory virus synchronization In concentrations that do not affect the cells. However, some viruses, such as HIV, They are able to use Alternative routes Therefore, the drug is not useful to prevent them.
Chronic inflammation
This study also helps to understand why regulates the production of some proteins associated with Chronic inflammation, Like IL -6, as they have already reported in previous articles. This feature, accompanied by its antiviral character, led to the launch of a medical examination Continued Govid, Headed by the Foundation against infections, where It may fight against both virus and related inflammation.
Most antivirals are designed Attack directly to the virus. However, due to the appearance of rapid evolution and variations of viruses, These treatments become useless. In addition, to create specific antivirals a Elaborate knowledge of each virus, This prevents rapid response to new infections. VirtuallyDrugs targeting human molecules They don’t have these limits. Explosing the antivirus of these drugs through their molecular track provides a “unique opportunity” to find new applications and applications, illustrating the irigica.
